Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06639802

Effects of Hand Arm Bimanual Intensive Therapy Including Lower Extremity on Balance and Coordination in Ataxic Cerebral Palsy

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
23 (estimated)
Sponsor
Foundation University Islamabad · Academic / Other
Sex
All
Age
6 Years – 15 Years
Healthy volunteers
Not accepted

Summary

Ataxic cerebral palsy is an abnormal movement or posture pattern accompanied by a loss of coordinated muscle action, resulting in movements that lack proper force, rhythm, or accuracy. Ataxic CP is classified into cerebellar ataxia and ataxic diplegia. In Cerebellar Ataxia, the cerebellum is hypo-plastic or malformed which impairs the integration of brain signals required for coordinating coordinated movement and balance. This study aimed to determine the effect of HABIT-ILE on the balance and coordination of children with cerebellar ataxic cerebral palsy.

Detailed description

OBJECTIVES: The objectives of this study are: 1. To determine the effect of HABIT-ILE on the coordination of children with cerebellar ataxic cerebral palsy. 2. To determine the effect of HABIT-ILE on the balance of children with cerebellar ataxic cerebral palsy. HYPOTHESIS: Alternate Hypothesis: There will be statistically significant differences in balance and coordination after HABIT-ILE in ataxic cerebral palsy.(P\>0.05) Null Hypothesis: There will be no statistically significant differences in balance and cooordination after HABIT-ILE in ataxic cerebral palsy.(P\>0.05) Research Design: Experimental study. Quasi-experimental Clinical setting: Al-Farabi Special Education Institute Islamabad Study duration: one year from Feb 2024 to 2025. Selection Criteria: Inclusion Criteria 1. Age group: 6 - 15 years. 2. Gender: Both males and females. 3. Cerebellar Ataxic cerebral palsy \[1\] 4. Gross motor function classification system level I and II. 5. Capable of following instructions and completing all necessary tests and tasks Exclusion Criteria 1. Uncontrolled epilepsy 2. Orthopedic surgery within the past 6 months, 3. Have visual, hearing impairments (diagnosed). Sampling technique: convenicence sampling Outcome Measures: 1. Pediatric Balance Scale \[2\] 2. Scale for the Assessment and Rating of Ataxia \[3\] 3. Gross Motor Function Classification System - Expanded \& Revised (GMFCS - E\&R) \[4\] Data analysis techniques: Data will be analyzed using SPSS version 20.0.0. Significance of the study: Cerebellar ataxic cerebral palsy is characterized by hypoplasia or malformations of the cerebellum, which hinders the integration of neural information necessary for coordination and balance. HABIT-ILE aims to collectively target the whole body both upper and lower extremity along with trunk in intensive therapy comprising of fun and playful goal oriented tasks in order to improve balance and coordination. So this research will find out effects of HABIT-ILE on balance and coordination of children with cerebellar ataxic cerebral palsy. Positive research outcome can contribute to better independence. This study will add data in the limited literature of ataxic cerebral palsy.

Conditions

Interventions

TypeNameDescription
OTHERHand Arm Bimanual Intensive therapy including lower extremity (HABIT-ILE)HABIT-ILE is continuous intervention applied for 50-90 hours over two weeks. We will design the activities based on the findings of the initial assessments (T0) and the customized functional goals that were previously discussed with the parents (e.g., drinking on one\'s own without spilling, using one hand to hold a book while turning pages with the other, removing a t-shirt, etc.). HABIT-ILE activities are presented as games and the whole environment is arranged in such a way that children perceive the therapy as fun. Progression of difficulty depend upon success in performance of current level. Specific bi-manual activities are selected on basis of child's motor abilities, age and interest.

Timeline

Start date
2024-04-10
Primary completion
2024-11-01
Completion
2024-12-01
First posted
2024-10-15
Last updated
2024-10-15

Locations

1 site across 1 country: Pakistan

Source: ClinicalTrials.gov record NCT06639802. Inclusion in this directory is not an endorsement.